DeForte S, Uversky VN (2017) Not an exception to the rule: the functional significance of intrinsically disordered protein regions in enzymes
Biopharm Drug Dispos 19(7):465472 Meiqun C, Gui Z, Kehuan S, Zhengzhi W (2011) Application of bioinformatics technique to screen of differentially expressed proteins in serums of breast cancer patients with white and yellow coating
Drucker of Lunenfeld-Tanenbaum Research Institute, University of Toronto, evaluated the efficacy and safety of glucagon-like peptide 1 receptor agonists (GLP-1RA) for type 2 diabetes and obesity and explored their potential for new indications
Abstract The development of tirzepatide, a first in class dual glucose dependent insulinotropic polypeptide and glucagon like peptide 1 receptor agonist, represents a potentially transformative advance in the management of type 2 diabetes and obesity
Protocol 4: anti-aging and longevity (3-4 peptides) Goal: Comprehensive age-management targeting multiple systems Peptides: Epithalon : 5-10mg daily for 10-20 days, cycle 2-3 times yearly GHK-Cu : 1-2mg daily or topically for skin and tissue support CJC-1295 + Ipamorelin: Standard GH-releasing protocol Optional fourth: Pinealon for neurological support Why this works: Epithalon extends telomeres and reactivates telomerase in somatic cells
